Petco Q1 2026 Earnings Mixed; Shares Fall

Petco Q1 2026 earnings showed positive comps but a wider GAAP loss and EPS miss that pressured pre-market trading; company reaffirmed FY guidance.

June 04, 2026·2 min read
View all news articles
Flat vector pet-store shelf with a dimming spotlight, evoking Petco Q1 2026 earnings and pre-market selloff.

KEY TAKEAWAYS

  • Net sales were $1.5 billion and comparable-store sales grew 0.7%.
  • Gross margin rose 21 basis points to 38.4% and adjusted EBITDA rose to $97 million.
  • GAAP diluted EPS was negative $0.05, missing consensus by $0.06; shares fell nearly 13% pre-market.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

Petco Health and Wellness Company, Inc. (Nasdaq: WOOF) reported Q1 2026 earnings on June 3, 2026, showing a return to positive comparable-store sales and improved margins under its Phase 3 "Reach for the Sky" strategy. However, a wider-than-expected GAAP loss and earnings-per-share (EPS) miss pressured shares in pre-market trading.

Q1 Results and Margins

Net sales reached $1.5 billion, up 0.2% year over year, while comparable-store sales rose 0.7%, marking a return to positive growth. Gross profit totaled $574.4 million, with gross margin expanding 21 basis points to 38.4%. GAAP operating income increased 50.5% to $24.6 million. Adjusted EBITDA, a proxy for operating profit, rose 8.8% to $97.3 million.

Reported GAAP diluted EPS was negative $0.05, missing the analyst consensus of negative $0.01 by $0.06. Management described the quarter as early validation of its plan: "Our strong first-quarter results, highlighted by positive comparable sales and profitability that exceeded our outlook, provide clear, early validation that our Phase 3 'Reach for the Sky' strategy is working." [source:5]

Guidance Reaffirmed and Strategy

Petco reaffirmed its fiscal-year 2026 outlook and provided a Q2 2026 outlook in its June 3 press release. Secondary summaries cite fiscal 2026 net-sales guidance between $5.96 billion and $6.05 billion and adjusted EBITDA guidance of $415 million to $430 million. Management noted a recent tariff refund supports the EBITDA outlook.

The company emphasized priorities including product improvements, services growth, store experience, and omnichannel execution as key to sustaining progress. Despite these positives, shares fell nearly 13% in pre-market trading on June 4, 2026.

The quarter highlighted the tradeoff facing Petco: early margin gains and an affirmed outlook suggest strategic progress, but the EPS shortfall focused investor attention on converting operating improvements into consistent GAAP profitability.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

Read other top news stories

Cerebras Stock Climbs After Wall Street Buy Calls

Cerebras Stock Climbs After Wall Street Buy Calls

Cerebras stock rallied after nine brokerages initiated coverage on June 8, 2026, supporting a near-term rerating as analysts cited wafer-scale chips.

Intel Stock Surges on Reported Google, Nvidia Foundry Deals

Intel Stock Surges on Reported Google, Nvidia Foundry Deals

Intel stock surges after reports of Google TPU orders and Nvidia tests of Intel's advanced process; lack of filings raises verification risk for traders.

SanDisk Stock Climbs Then Pulls Back After Upgrades

SanDisk Stock Climbs Then Pulls Back After Upgrades

SanDisk stock drew June 8 analyst 12-month target lifts after an April blockbuster quarter; traders weigh May AI gains versus NAND supply concerns.

Ingredion Tate & Lyle Takeover Agreed

Ingredion Tate & Lyle Takeover Agreed

Ingredion Tate & Lyle takeover is an all-cash $3.6 billion offer that preserves dividends, wins 17.1% undertakings and tightens near-term deal certainty.

Amazon Corning Fiber-Optic Deal Adds North Carolina Jobs

Amazon Corning Fiber-Optic Deal Adds North Carolina Jobs

Amazon Corning fiber-optic deal expands U.S. manufacturing and adds 1,000 jobs while positioning Corning as a supplier for Amazon's data centers.

Roche Nurix Deal Advances BTK Program

Roche Nurix Deal Advances BTK Program

Roche Nurix deal sets U.S. co-commercialization and outlines near-term clinical catalysts, with material deal economics that matter to biotech investors.